The thioredoxin (Trx) tag enhances the solubility and stability of the fusion protein, while the MMP-2/9-cleavable peptide (PVGLIG) ensures responsiveness to the tumor microenvironment by being cleaved in the presence of overexpressed MMP-2/9 enzymes. The gene discussed is TXN; the disease is neoplasm.